Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4α, GCK and TCF1 in patients with MODY in Israel

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 8, 2007, Pages 909-921

  Stern, E ^a   Strihan, C ^a   Potievsky, O ^a   Nimri, R ^a   Shalitin, S ^a   Cohen, O ^b   Shehadeh, N ^c   Weintrob, N ^a   Phillip, Moshe ^a   Gat Yablonski, G ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Deletion; GCK; HNF 4 ; Israel; MODY; TCF1

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFONYLUREA; TRANSCRIPTION FACTOR 7;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIET THERAPY; ETHNICITY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ISRAEL; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; MUTATIONAL ANALYSIS; PROTEIN ANALYSIS; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 34648836843     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2007.20.8.909     Document Type: Article

References (39)

1. Froguel P, Velho G. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 1999; 10: 142-146.
2. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980.
3. Gat-Yablonski G, Shalitin S, Phillip M. Maturity onset diabetes of the young. Pediatr Endocrinol Rev 2006; 3 (Suppl 3); 350-256.
4. Froguel P, Zonali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
5. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458-460.
6. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI. Mutations in the hepatocyte nuclear factor-1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384: 455-458.
7. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17: 138-139.
8. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 1997; 17: 384-385.
9. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saed M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999; 23: 323-328.
10. Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bjorkhaug L, Sagen JV, Aksnes L, Sovik O, Lombardo D, Molven A, Njolstad PR. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006; 38: 54-62.
11. Lindner TH, Cockburn BN, Bell GI. Molecular genetics of MODY in Germany. Diabetologia 1999; 42: 121-123.
12. Costa A, Bescos M, Velho G, Chevre J, Vidal J, Sesmilo G, Bellanne-Chantelot C, Froguel P, Casamitjana R, Rivera-Fillat F, Gomis R, Conget I. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families. Eur J Endocrinol 2000; 142: 380-386.
13. Pruhova S, Ek J, Lebl J, Sumnik Z, Saudek F, Andel M, Pedersen O, Hansen T. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4 alpha, GCK and HNF-1 alpha. Diabetologia 2003; 46:291-295.
14. Gragnoli C, Cockburn BN, Chiaramonte F, Gorini A, Marietti G, Marozzi G, Signorini AM. Early-onset type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor I alpha and glucokinase. Diabetologia 2001; 44: 1326-1329.
15. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001; 50 (Suppl 1): S94-S100.
16. Barrio R, Bellanne-Chantelot C, Moreno JC, Morel V, Calle H, Alonso M, Mustieles C. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002; 87: 2532-2539.
17. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT. Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1 alpha and glucokinase mutations. Diabetes 2001; 50 (Suppl 1): S101-S107.
18. Boileau P, Boileau P, Wolfrum C, Shih DQ, Yang TA, Wolkoff AW, Stoffel M. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1-alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3). Diabetes 2002; 51 (Suppl 3): S343-S358.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
20. Myers RM, Fischer SG, Maniatis T, Lerman LS. Modification of the melting properties of duplex DNA by attachment of a GC-rich DNA sequence as determined by denaturing gradient gel electrophoresis. Nucleic Acids Res 1985; 13: 3111-3129.
21. Gat-Yablonski G, Lazar L, Pertzelan A, Phillip M. A novel mutation in PIT-l: phenotypic variability in familial combined pituitary hormone deficiency. J Pediatr Endocrinol Metab 2002; 15: 325-331.
22. Frayling TM, Bulman MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 1997; 46: 720-725.
23. Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F, Toni S, Cherubini V, Guazzarotti L, Sulli N, Matschinsky FM, Lorini R, Iafusco D, Barbetti F; Italian Society of Paediatic Endocrinology and Diabetes (SIEDP). High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). Diabetologia 2001; 44: 898-905.
24. Velho G, Blanche H, Vaxillaire M, Bellanne-Chantelot C, Pardini VC, Timsit J, Passa P, Deschamps I, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI, Froguel P. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40: 217-224.
25. Johansen A, EK J, Mortensen HB, Pedersen O, Hansen T. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocrinol Metab 2005; 90: 4607-4614.
26. Duds K, Chi YI, Shoelson SE. Structural basis for HNF-4 alpha activation by ligand and coactivator binding. J Biol Chem 2004; 279: 23311-23316.
27. Stoffel M, Froguel P, Takeds J, Zouali H, Vionnet N. Nishi S, Weber IT, Harrison RW, Pilkis SJ, Lesage S, Vaxillaire M, Velho G, Sun F, Iris F, Passa P, Cohen D, Bell GI. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci USA 1992; 89: 7698-7702.
28. Cao H, Shorey S, Robinson J, Metzger DL, Stewart L, Cummings E, Hegele RA. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat 2002; 20: 478-479.
29. Miller SP, Anand GR, Karscnia EJ, Bell GI, LaPorte DC, Lange AJ. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes 1999; 48: 1645-1651.
30. Chi YI, Frantz JD, Oh BC, Hansen L, Dha-Paganon S, Shoelson SE. Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol Cell 2002; 10: 1129-1137.
31. Tonooka N, Tomura H, Takahashi Y, Onigata K, Kikuchi N, Horikawa Y, Mori M, Takeda J. High frequency of mutations in the HNF-1 alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance. Diabetologia 2002; 45: 1709-1712.
32. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum Mutat 2000; 16: 377-385.
33. Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyagawa J, Okita K, Yoshiuchi I, Miyazaki J, Noguchi T, Nakajima H, Namha M, Hanafusa T, Matsuzawa Y. Mutation P291 fsinsC in the transcription factor hepatocyte nuclear factor-1 alpha is dominant negative. Diabetes 1998; 47: 1231-1235.
34. Chevre JC, Hani EH, Boutin P, Vaxillaire M, Blanche H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanne-Chantelot C, Velho G, Froguel P. Mutation greening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 1998; 41: 1017-1023.
35. Vaxillaire M, Rouard M, Yamagata K, Ode N, Kaisaki PJ, Boriraj VV, Chevre JC, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, Froguel P. Identification of nine novel mutations in the hapatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 1997; 6: 583-586.
36. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Moller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O. Novel MODY3 mutations in the hepatocyte nuclear factor-1 alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 1997; 46: 726-730.
37. Urhammer SA, Moller AM, Nyholm B, Ekstrom CT, Eiberg H, Clausen JO, Hansen T, Pedersen O, Schmitz O. The effect of two frequent amino acid variants of the hepetocyte nuclenr factor-1 alpha gene on estimates of the pancreatic beta-cell function in Caucasian glucosetolerant first-degree relatives of type 2 diabetic patients. J Clin Endocrinol Metab 1998; 83: 3992-3995.
38. Chiu KC, Chuang LM, Ryu, JM, Tsai GP, Saad MF. The I27L amino acid polymorphism of hepatic nuclear factor-1-alpha is associated with insulin resistance. J Clin Endocrinol Metab 2000; 85: 2178-2183.
39. Urhammer SA, Fridberg M, Hansen T, Rasmussen SK, Moller AM, Clausen JO, Pedersen O. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 1997; 46: 912-916.